Effettuare il login Iscriviti gratis

Abeona Therapeutics Inc Dipendenti

Cos'è Dipendenti di Abeona Therapeutics Inc?

Dipendenti di Abeona Therapeutics Inc è 99

Qual è la definizione di Dipendenti?

I dipendenti lavorano a pagamento, che può essere sotto forma di retribuzione oraria, a cottimo o salario annuale, a seconda del tipo di lavoro svolto da un dipendente o del settore in cui lavora.

Employment is a relationship between two parties, usually based on a contract where work is paid for, where one party, which may be a corporation, for profit, not-for-profit organization, co-operative or other entity is the employer and the other is the employee.

Employees in some fields or sectors may receive gratuities, bonus payment or stock options. In some types of employment, employees may receive benefits in addition to payment. Benefits can include health insurance, housing, disability insurance or use of a gym. Employment is typically governed by employment laws or regulations or legal contracts.

Dipendenti di aziende nel Health Care settore su NASDAQ rispetto a Abeona Therapeutics Inc

Cosa fa Abeona Therapeutics Inc?

abeona therapeutics inc. (nasdaq: $abeo), is a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare genetic diseases. abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases. abeona's lead programs include abo-102 (aav-sgsh), an adeno-associated virus (aav) based gene therapy for sanfilippo syndrome type a (mps iiia) and eb-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (rdeb). abeona is also developing abo-101 (aav-naglu) for sanfilippo syndrome type b (mps iiib), abo-201 (aav-cln3) gene therapy for juvenile batten disease (jncl), abo-202 (aav-cln1) for treatment of infantile batten disease (incl), eb-201 for epidermolysis bullosa (eb), abo-301 (aav-fancc) for fanconi anemia (fa) disorder and abo-302 using a novel crispr/cas9-based gene editing approach to gene t

Aziende con dipendenti simili a Abeona Therapeutics Inc